APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptives

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Selected research

Market Outlook & Growth Opportunities

Global Contraceptives Market Outlook and Growth Opportunities 2026

26 December 2025208 pages

Choose your research edition.

Industry ResearchContraceptives Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptives Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptives Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptives Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.

The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

Read the full market overview

This report provides an overview of the global Contraceptives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptives market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptives Segment by Company

Bayer AG

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

Merck & Co., Inc

Actavis, Inc.

Johnson & Johnson

Gedeon Richter

Novo Nordisk A/S

ZiZhu

Baijingyu

Huazhong

Sine

Reckitt

AbbVie

Church & Dwight

The Cooper Companies

TherapeuticsMD

Afaxys

Mithra Pharmaceuticals

Contraceptives Segment by Type

Pills

Injectable

Condoms

Vaginal Rings

IUDs

Subdermal Implants

Others

Contraceptives Segment by End User

15–24 years

25–34 years

35–44 years

Above 44 years

Contraceptives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Contraceptives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Contraceptives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Contraceptives significant trends, drivers, influence factors in global and regions.

6. To analyze Contraceptives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contraceptives industry.

Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Contraceptives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Contraceptives Industry Trends Table 2. Contraceptives Industry Drivers Table 3. Contraceptives Industry Opportunities and Challenges Table 4. Contraceptives Industry Restraints Table 5. Global Contraceptives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Contraceptives Revenue Share by Company (2021-2026) Table 7. Global Contraceptives Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Contraceptives Sales Volume Share by Company (2021-2026) Table 9. Global Contraceptives Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Contraceptives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Contraceptives Key Company Manufacturing Base & Headquarters Table 12. Global Contraceptives Company, Product Type & Application Table 13. Global Contraceptives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pills Table 18. Significant Companies of Injectable Table 19. Significant Companies of Condoms Table 20. Significant Companies of Vaginal Rings Table 21. Significant Companies of IUDs Table 22. Significant Companies of Subdermal Implants Table 23. Significant Companies of Others Table 24. Global Contraceptives Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 25. Global Contraceptives Sales Volume by Type (2021-2026) & (M Units) Table 26. Global Contraceptives Sales Volume by Type (2027-2032) & (M Units) Table 27. Global Contraceptives Sales Volume Share by Type (2021-2026) Table 28. Global Contraceptives Sales Volume Share by Type (2027-2032) Table 29. Global Contraceptives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Contraceptives Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Contraceptives Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Contraceptives Sales Value Share by Type (2021-2026) Table 33. Global Contraceptives Sales Value Share by Type (2027-2032) Table 34. Significant Companies of 15–24 years Table 35. Significant Companies of 25–34 years Table 36. Significant Companies of 35–44 years Table 37. Significant Companies of Above 44 years Table 38. Global Contraceptives Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 39. Global Contraceptives Sales Volume by Application (2021-2026) & (M Units) Table 40. Global Contraceptives Sales Volume by Application (2027-2032) & (M Units) Table 41. Global Contraceptives Sales Volume Share by Application (2021-2026) Table 42. Global Contraceptives Sales Volume Share by Application (2027-2032) Table 43. Global Contraceptives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Contraceptives Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Contraceptives Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Contraceptives Sales Value Share by Application (2021-2026) Table 47. Global Contraceptives Sales Value Share by Application (2027-2032) Table 48. Global Contraceptives Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 49. Global Contraceptives Sales by Region (2021-2026) & (M Units) Table 50. Global Contraceptives Sales Market Share by Region (2021-2026) Table 51. Global Contraceptives Sales by Region (2027-2032) & (M Units) Table 52. Global Contraceptives Sales Market Share by Region (2027-2032) Table 53. Global Contraceptives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Contraceptives Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Contraceptives Sales Value Share by Region (2021-2026) Table 56. Global Contraceptives Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Contraceptives Sales Value Share by Region (2027-2032) Table 58. Global Contraceptives Market Average Price (USD/Unit) by Region (2021-2026) Table 59. Global Contraceptives Market Average Price (USD/Unit) by Region (2027-2032) Table 60. Global Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 61. Global Contraceptives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Contraceptives Sales by Country (2021-2026) & (M Units) Table 63. Global Contraceptives Sales Market Share by Country (2021-2026) Table 64. Global Contraceptives Sales by Country (2027-2032) & (M Units) Table 65. Global Contraceptives Sales Market Share by Country (2027-2032) Table 66. Global Contraceptives Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Contraceptives Sales Value Market Share by Country (2021-2026) Table 68. Global Contraceptives Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Contraceptives Sales Value Market Share by Country (2027-2032) Table 70. Bayer AG Company Information Table 71. Bayer AG Business Overview Table 72. Bayer AG Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Bayer AG Contraceptives Product Portfolio Table 74. Bayer AG Recent Development Table 75. Pfizer, Inc Company Information Table 76. Pfizer, Inc Business Overview Table 77. Pfizer, Inc Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Pfizer, Inc Contraceptives Product Portfolio Table 79. Pfizer, Inc Recent Development Table 80. Teva Pharmaceutical Industries Ltd Company Information Table 81. Teva Pharmaceutical Industries Ltd Business Overview Table 82. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio Table 84. Teva Pharmaceutical Industries Ltd Recent Development Table 85. Merck & Co., Inc Company Information Table 86. Merck & Co., Inc Business Overview Table 87. Merck & Co., Inc Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Merck & Co., Inc Contraceptives Product Portfolio Table 89. Merck & Co., Inc Recent Development Table 90. Actavis, Inc. Company Information Table 91. Actavis, Inc. Business Overview Table 92. Actavis, Inc. Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Actavis, Inc. Contraceptives Product Portfolio Table 94. Actavis, Inc. Recent Development Table 95. Johnson & Johnson Company Information Table 96. Johnson & Johnson Business Overview Table 97. Johnson & Johnson Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Johnson & Johnson Contraceptives Product Portfolio Table 99. Johnson & Johnson Recent Development Table 100. Gedeon Richter Company Information Table 101. Gedeon Richter Business Overview Table 102. Gedeon Richter Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Gedeon Richter Contraceptives Product Portfolio Table 104. Gedeon Richter Recent Development Table 105. Novo Nordisk A/S Company Information Table 106. Novo Nordisk A/S Business Overview Table 107. Novo Nordisk A/S Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Novo Nordisk A/S Contraceptives Product Portfolio Table 109. Novo Nordisk A/S Recent Development Table 110. ZiZhu Company Information Table 111. ZiZhu Business Overview Table 112. ZiZhu Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. ZiZhu Contraceptives Product Portfolio Table 114. ZiZhu Recent Development Table 115. Baijingyu Company Information Table 116. Baijingyu Business Overview Table 117. Baijingyu Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Baijingyu Contraceptives Product Portfolio Table 119. Baijingyu Recent Development Table 120. Huazhong Company Information Table 121. Huazhong Business Overview Table 122. Huazhong Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Huazhong Contraceptives Product Portfolio Table 124. Huazhong Recent Development Table 125. Sine Company Information Table 126. Sine Business Overview Table 127. Sine Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Sine Contraceptives Product Portfolio Table 129. Sine Recent Development Table 130. Reckitt Company Information Table 131. Reckitt Business Overview Table 132. Reckitt Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Reckitt Contraceptives Product Portfolio Table 134. Reckitt Recent Development Table 135. AbbVie Company Information Table 136. AbbVie Business Overview Table 137. AbbVie Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. AbbVie Contraceptives Product Portfolio Table 139. AbbVie Recent Development Table 140. Church & Dwight Company Information Table 141. Church & Dwight Business Overview Table 142. Church & Dwight Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 143. Church & Dwight Contraceptives Product Portfolio Table 144. Church & Dwight Recent Development Table 145. The Cooper Companies Company Information Table 146. The Cooper Companies Business Overview Table 147. The Cooper Companies Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 148. The Cooper Companies Contraceptives Product Portfolio Table 149. The Cooper Companies Recent Development Table 150. TherapeuticsMD Company Information Table 151. TherapeuticsMD Business Overview Table 152. TherapeuticsMD Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 153. TherapeuticsMD Contraceptives Product Portfolio Table 154. TherapeuticsMD Recent Development Table 155. Afaxys Company Information Table 156. Afaxys Business Overview Table 157. Afaxys Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 158. Afaxys Contraceptives Product Portfolio Table 159. Afaxys Recent Development Table 160. Mithra Pharmaceuticals Company Information Table 161. Mithra Pharmaceuticals Business Overview Table 162. Mithra Pharmaceuticals Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 163. Mithra Pharmaceuticals Contraceptives Product Portfolio Table 164. Mithra Pharmaceuticals Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Contraceptives Distributors List Table 168. Contraceptives Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Contraceptives Product Image Figure 2. Global Contraceptives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Contraceptives Sales (2021-2032) & (M Units) Figure 5. Global Contraceptives Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Contraceptives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pills Image Figure 10. Injectable Image Figure 11. Condoms Image Figure 12. Vaginal Rings Image Figure 13. IUDs Image Figure 14. Subdermal Implants Image Figure 15. Others Image Figure 16. Global Contraceptives Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 17. Global Contraceptives Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Contraceptives Sales Volume Share by Type (2021-2032) Figure 19. Global Contraceptives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Contraceptives Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Contraceptives Sales Value Share by Type (2021-2032) Figure 22. 15–24 years Image Figure 23. 25–34 years Image Figure 24. 35–44 years Image Figure 25. Above 44 years Image Figure 26. Global Contraceptives Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 27. Global Contraceptives Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Contraceptives Sales Volume Share by Application (2021-2032) Figure 29. Global Contraceptives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Contraceptives Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Contraceptives Sales Value Share by Application (2021-2032) Figure 32. Global Contraceptives Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 33. Global Contraceptives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Contraceptives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Contraceptives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Contraceptives Sales Value (2021-2032) & (US$ Million) Figure 37. North America Contraceptives Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Contraceptives Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Contraceptives Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Contraceptives Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Contraceptives Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Contraceptives Sales Value (2021-2032) & (US$ Million) Figure 43. South America Contraceptives Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Contraceptives Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Contraceptives Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Contraceptives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Contraceptives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Contraceptives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Contraceptives Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Contraceptives Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Injectable
  • Condoms
  • Vaginal Rings
  • IUDs
  • Subdermal Implants
  • Others
Applications
  • 15–24 years
  • 25–34 years
  • 35–44 years
  • Above 44 years
Companies covered
  • Bayer AG
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc
  • Actavis, Inc.
  • Johnson & Johnson
  • Gedeon Richter
  • Novo Nordisk A/S
  • ZiZhu
  • Baijingyu
  • Huazhong
  • Sine
  • Reckitt
  • AbbVie
  • Church & Dwight
  • The Cooper Companies
  • TherapeuticsMD
  • Afaxys
  • Mithra Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contraceptives Sales Value (2021-2032)
  4. 1.2.2 Global Contraceptives Sales Volume (2021-2032)
  5. 1.2.3 Global Contraceptives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Contraceptives Market Dynamics
  1. 2.1 Contraceptives Industry Trends
  2. 2.2 Contraceptives Industry Drivers
  3. 2.3 Contraceptives Industry Opportunities and Challenges
  4. 2.4 Contraceptives Industry Restraints
3 Contraceptives Market by Company
  1. 3.1 Global Contraceptives Company Revenue Ranking in 2025
  2. 3.2 Global Contraceptives Revenue by Company (2021-2026)
  3. 3.3 Global Contraceptives Sales Volume by Company (2021-2026)
  4. 3.4 Global Contraceptives Average Price by Company (2021-2026)
  5. 3.5 Global Contraceptives Company Ranking (2024-2026)
  6. 3.6 Global Contraceptives Company Manufacturing Base and Headquarters
  7. 3.7 Global Contraceptives Company Product Type and Application
  8. 3.8 Global Contraceptives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Contraceptives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Contraceptives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Contraceptives Market by Type
  1. 4.1 Contraceptives Type Introduction
  2. 4.1.1 Pills
  3. 4.1.2 Injectable
  4. 4.1.3 Condoms
  5. 4.1.4 Vaginal Rings
  6. 4.1.5 IUDs
  7. 4.1.6 Subdermal Implants
  8. 4.1.7 Others
  9. 4.2 Global Contraceptives Sales Volume by Type
  10. 4.2.1 Global Contraceptives Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Contraceptives Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Contraceptives Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Contraceptives Sales Value by Type
  14. 4.3.1 Global Contraceptives Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Contraceptives Sales Value by Type (2021-2032)
  16. 4.3.3 Global Contraceptives Sales Value Share by Type (2021-2032)
5 Contraceptives Market by Application
  1. 5.1 Contraceptives Application Introduction
  2. 5.1.1 15–24 years
  3. 5.1.2 25–34 years
  4. 5.1.3 35–44 years
  5. 5.1.4 Above 44 years
  6. 5.2 Global Contraceptives Sales Volume by Application
  7. 5.2.1 Global Contraceptives Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Contraceptives Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Contraceptives Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Contraceptives Sales Value by Application
  11. 5.3.1 Global Contraceptives Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Contraceptives Sales Value by Application (2021-2032)
  13. 5.3.3 Global Contraceptives Sales Value Share by Application (2021-2032)
6 Contraceptives Regional Sales and Value Analysis
  1. 6.1 Global Contraceptives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptives Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptives Sales by Region: 2021-2026
  4. 6.2.2 Global Contraceptives Sales by Region (2027-2032)
  5. 6.3 Global Contraceptives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Contraceptives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Contraceptives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Contraceptives Sales Value by Region (2027-2032)
  9. 6.5 Global Contraceptives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Contraceptives Sales Value (2021-2032)
  12. 6.6.2 North America Contraceptives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Contraceptives Sales Value (2021-2032)
  15. 6.7.2 Europe Contraceptives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Contraceptives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Contraceptives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Contraceptives Sales Value (2021-2032)
  21. 6.9.2 South America Contraceptives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Contraceptives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Contraceptives Sales Value Share by Country, 2025 VS 2032
7 Contraceptives Country-level Sales and Value Analysis
  1. 7.1 Global Contraceptives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Contraceptives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Contraceptives Sales by Country (2021-2032)
  4. 7.3.1 Global Contraceptives Sales by Country (2021-2026)
  5. 7.3.2 Global Contraceptives Sales by Country (2027-2032)
  6. 7.4 Global Contraceptives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Contraceptives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Contraceptives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Contraceptives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Contraceptives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Contraceptives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Contraceptives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Contraceptives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Contraceptives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Contraceptives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Contraceptives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Contraceptives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Contraceptives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Contraceptives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Contraceptives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Contraceptives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Contraceptives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Contraceptives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Contraceptives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Contraceptives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Contraceptives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Contraceptives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Contraceptives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Contraceptives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Contraceptives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Contraceptives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Contraceptives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Contraceptives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Contraceptives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Contraceptives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Contraceptives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Contraceptives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Contraceptives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Contraceptives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Contraceptives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Contraceptives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Contraceptives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Contraceptives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Contraceptives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Contraceptives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Contraceptives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Contraceptives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Contraceptives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Contraceptives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Contraceptives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Contraceptives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Contraceptives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Contraceptives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Contraceptives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Contraceptives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Contraceptives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Contraceptives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Contraceptives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Contraceptives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Contraceptives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Contraceptives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Contraceptives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Contraceptives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Contraceptives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Contraceptives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Contraceptives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Contraceptives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Contraceptives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Contraceptives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Contraceptives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Contraceptives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Contraceptives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Contraceptives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Contraceptives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Contraceptives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Contraceptives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Contraceptives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Contraceptives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Contraceptives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Contraceptives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Contraceptives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Contraceptives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Contraceptives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Contraceptives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Contraceptives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Contraceptives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Contraceptives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Contraceptives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Contraceptives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Contraceptives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Contraceptives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Contraceptives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer AG
  2. 8.1.1 Bayer AG Company Information
  3. 8.1.2 Bayer AG Business Overview
  4. 8.1.3 Bayer AG Contraceptives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer AG Contraceptives Product Portfolio
  6. 8.1.5 Bayer AG Recent Developments
  7. 8.2 Pfizer, Inc
  8. 8.2.1 Pfizer, Inc Company Information
  9. 8.2.2 Pfizer, Inc Business Overview
  10. 8.2.3 Pfizer, Inc Contraceptives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer, Inc Contraceptives Product Portfolio
  12. 8.2.5 Pfizer, Inc Recent Developments
  13. 8.3 Teva Pharmaceutical Industries Ltd
  14. 8.3.1 Teva Pharmaceutical Industries Ltd Company Information
  15. 8.3.2 Teva Pharmaceutical Industries Ltd Business Overview
  16. 8.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
  18. 8.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
  19. 8.4 Merck & Co., Inc
  20. 8.4.1 Merck & Co., Inc Company Information
  21. 8.4.2 Merck & Co., Inc Business Overview
  22. 8.4.3 Merck & Co., Inc Contraceptives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co., Inc Contraceptives Product Portfolio
  24. 8.4.5 Merck & Co., Inc Recent Developments
  25. 8.5 Actavis, Inc.
  26. 8.5.1 Actavis, Inc. Company Information
  27. 8.5.2 Actavis, Inc. Business Overview
  28. 8.5.3 Actavis, Inc. Contraceptives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Actavis, Inc. Contraceptives Product Portfolio
  30. 8.5.5 Actavis, Inc. Recent Developments
  31. 8.6 Johnson & Johnson
  32. 8.6.1 Johnson & Johnson Company Information
  33. 8.6.2 Johnson & Johnson Business Overview
  34. 8.6.3 Johnson & Johnson Contraceptives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Johnson & Johnson Contraceptives Product Portfolio
  36. 8.6.5 Johnson & Johnson Recent Developments
  37. 8.7 Gedeon Richter
  38. 8.7.1 Gedeon Richter Company Information
  39. 8.7.2 Gedeon Richter Business Overview
  40. 8.7.3 Gedeon Richter Contraceptives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Gedeon Richter Contraceptives Product Portfolio
  42. 8.7.5 Gedeon Richter Recent Developments
  43. 8.8 Novo Nordisk A/S
  44. 8.8.1 Novo Nordisk A/S Company Information
  45. 8.8.2 Novo Nordisk A/S Business Overview
  46. 8.8.3 Novo Nordisk A/S Contraceptives Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
  48. 8.8.5 Novo Nordisk A/S Recent Developments
  49. 8.9 ZiZhu
  50. 8.9.1 ZiZhu Company Information
  51. 8.9.2 ZiZhu Business Overview
  52. 8.9.3 ZiZhu Contraceptives Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ZiZhu Contraceptives Product Portfolio
  54. 8.9.5 ZiZhu Recent Developments
  55. 8.10 Baijingyu
  56. 8.10.1 Baijingyu Company Information
  57. 8.10.2 Baijingyu Business Overview
  58. 8.10.3 Baijingyu Contraceptives Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Baijingyu Contraceptives Product Portfolio
  60. 8.10.5 Baijingyu Recent Developments
  61. 8.11 Huazhong
  62. 8.11.1 Huazhong Company Information
  63. 8.11.2 Huazhong Business Overview
  64. 8.11.3 Huazhong Contraceptives Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Huazhong Contraceptives Product Portfolio
  66. 8.11.5 Huazhong Recent Developments
  67. 8.12 Sine
  68. 8.12.1 Sine Company Information
  69. 8.12.2 Sine Business Overview
  70. 8.12.3 Sine Contraceptives Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sine Contraceptives Product Portfolio
  72. 8.12.5 Sine Recent Developments
  73. 8.13 Reckitt
  74. 8.13.1 Reckitt Company Information
  75. 8.13.2 Reckitt Business Overview
  76. 8.13.3 Reckitt Contraceptives Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Reckitt Contraceptives Product Portfolio
  78. 8.13.5 Reckitt Recent Developments
  79. 8.14 AbbVie
  80. 8.14.1 AbbVie Company Information
  81. 8.14.2 AbbVie Business Overview
  82. 8.14.3 AbbVie Contraceptives Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AbbVie Contraceptives Product Portfolio
  84. 8.14.5 AbbVie Recent Developments
  85. 8.15 Church & Dwight
  86. 8.15.1 Church & Dwight Company Information
  87. 8.15.2 Church & Dwight Business Overview
  88. 8.15.3 Church & Dwight Contraceptives Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Church & Dwight Contraceptives Product Portfolio
  90. 8.15.5 Church & Dwight Recent Developments
  91. 8.16 The Cooper Companies
  92. 8.16.1 The Cooper Companies Company Information
  93. 8.16.2 The Cooper Companies Business Overview
  94. 8.16.3 The Cooper Companies Contraceptives Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 The Cooper Companies Contraceptives Product Portfolio
  96. 8.16.5 The Cooper Companies Recent Developments
  97. 8.17 TherapeuticsMD
  98. 8.17.1 TherapeuticsMD Company Information
  99. 8.17.2 TherapeuticsMD Business Overview
  100. 8.17.3 TherapeuticsMD Contraceptives Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 TherapeuticsMD Contraceptives Product Portfolio
  102. 8.17.5 TherapeuticsMD Recent Developments
  103. 8.18 Afaxys
  104. 8.18.1 Afaxys Company Information
  105. 8.18.2 Afaxys Business Overview
  106. 8.18.3 Afaxys Contraceptives Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Afaxys Contraceptives Product Portfolio
  108. 8.18.5 Afaxys Recent Developments
  109. 8.19 Mithra Pharmaceuticals
  110. 8.19.1 Mithra Pharmaceuticals Company Information
  111. 8.19.2 Mithra Pharmaceuticals Business Overview
  112. 8.19.3 Mithra Pharmaceuticals Contraceptives Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
  114. 8.19.5 Mithra Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptives Value Chain Analysis
  2. 9.1.1 Contraceptives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptives Sales Mode & Process
  6. 9.2 Contraceptives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptives Distributors
  9. 9.2.3 Contraceptives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst